Tracking IV clot-busting treatment for stroke in China
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study is tracking patients in southwestern China who have had an acute ischemic stroke and received a clot-busting medicine through an IV. It aims to learn more about how well this treatment works and how it is used in real-world settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been diagnosed with an acute ischemic stroke (a stroke caused by a blood clot).
- You must have received a clot-dissolving medicine through an IV (intravenous thrombolysis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information on stroke patients who received the clot-dissolving drug tenecteplase. It aims to see how well the drug works and how safe it is in everyday hospital care in China.
This study tracks people who get a clot-busting medicine for a stroke more than 4.5 hours after symptoms start. It aims to see if this type of treatment is safe and helpful for patients who arrive later, such as after sleeping.
This trial tests whether giving a clot-busting drug to people with mild stroke symptoms (but no limb weakness) can improve recovery. It aims to see if this treatment is safe and helpful for this specific group.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This trial compares different ways to restore blood flow in people who have had a mild ischemic stroke. Doctors want to see which treatment approach is safest and most effective for improving recovery, using clot-busting medicine and/or a clot-removal procedure.
This trial tests whether a clot-busting drug given through a vein can safely and effectively treat strokes in people who also have active cancer. It aims to see if this treatment can improve recovery without increasing bleeding risks.
Hear when a new Stroke, Acute trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.